{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:10Z","timestamp":1761059110797},"reference-count":21,"publisher":"SLACK, Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.3928\/00904481-20100922-11","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T20:06:34Z","timestamp":1287432394000},"page":"667-674","source":"Crossref","is-referenced-by-count":4,"title":["Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis"],"prefix":"10.3928","volume":"39","author":[{"given":"James","family":"Treat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.129.1.92"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311906"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.126.1.43"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.06.017"},{"key":"e_1_3_1_6_2","first-page":"550","article-title":"HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese","volume":"14","author":"Ueta M","year":"2008","unstructured":"Ueta M, Tokunaga K, Sotozono C, et al. HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis. 2008;14:550\u2013555.","journal-title":"Mol Vis"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.09.029"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252"},{"key":"e_1_3_1_9_2","unstructured":"United States Department of Health and Human Services. January 25th 2010. Available at www.fda.gov\/Drugs\/DrugSafety\/Postmarket-DrugSafetyInformationforPatientsandProviders\/ucm107834.htm. Accessed September 21 2010."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)91746-5"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.07.044"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91152-2"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0287-9"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.131.5.539"},{"issue":"1","key":"e_1_3_1_15_2","first-page":"27","article-title":"Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis","volume":"73","author":"Patterson R","year":"1994","unstructured":"Patterson R, Miller M, Kaplan M, et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy. 1994;73(1):27\u201334.","journal-title":"Ann Allergy"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.490"},{"issue":"3","key":"e_1_3_1_17_2","first-page":"273","article-title":"Burn center care for patients with toxic epidermal necrolysis","volume":"180","author":"Kelemen JJ","year":"1995","unstructured":"Kelemen JJ, Cioffi WG, McManus WF, Mason AD, Pruitt BA. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg. 1995;180(3):273\u2013278.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"e_1_3_1_18_2","first-page":"537","article-title":"[Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis]","volume":"58","author":"Yamane Y","year":"2009","unstructured":"Yamane Y, Aihara M, Tatewaki S, et al. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis] Arerugi. 2009;58(5):537\u2013547. [Article in Japanese.]","journal-title":"Arerugi"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000070957"},{"issue":"2","key":"e_1_3_1_20_2","first-page":"115","article-title":"Bone marrow toxicity by silver sulfadiazine","volume":"177","author":"Gamelli RL","year":"1993","unstructured":"Gamelli RL, Paxton TP, O\u2019Reilly M. Bone marrow toxicity by silver sulfadiazine. Surg Gynecol Obstet. 1993;177(2):115\u2013120.","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181ca4290"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.slackinc.com\/doi\/resolver.asp?doi=10.3928\/00904481-20100922-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:59:01Z","timestamp":1683075541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/00904481-20100922-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.3928\/00904481-20100922-11"],"URL":"https:\/\/doi.org\/10.3928\/00904481-20100922-11","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}